Short Interest in Acutus Medical, Inc. (NASDAQ:AFIB) Decreases By 14.2%

Acutus Medical, Inc. (NASDAQ:AFIB) was the recipient of a large drop in short interest in March. As of March 31st, there was short interest totalling 845,200 shares, a drop of 14.2% from the March 15th total of 984,700 shares. Based on an average daily trading volume, of 2,250,000 shares, the days-to-cover ratio is presently 0.4 days. Currently, 4.5% of the shares of the company are short sold.

Acutus Medical Price Performance

Acutus Medical stock opened at $0.18 on Friday. Acutus Medical has a 52 week low of $0.16 and a 52 week high of $1.09. The company’s 50 day moving average price is $0.19 and its two-hundred day moving average price is $0.29. The company has a quick ratio of 2.22, a current ratio of 2.44 and a debt-to-equity ratio of 1.10. The stock has a market cap of $5.20 million, a P/E ratio of -0.14 and a beta of 0.19.

Hedge Funds Weigh In On Acutus Medical

Hedge funds have recently modified their holdings of the company. Bank of Montreal Can bought a new position in shares of Acutus Medical during the 1st quarter worth approximately $34,000. Cerity Partners LLC bought a new stake in shares of Acutus Medical in the 1st quarter worth approximately $48,000. Mirabella Financial Services LLP bought a new stake in shares of Acutus Medical in the 1st quarter worth approximately $48,000. Schonfeld Strategic Advisors LLC raised its holdings in shares of Acutus Medical by 1,065.1% in the 1st quarter. Schonfeld Strategic Advisors LLC now owns 170,100 shares of the company’s stock worth $128,000 after purchasing an additional 155,500 shares during the period. Finally, AQR Capital Management LLC raised its holdings in shares of Acutus Medical by 844.0% in the 2nd quarter. AQR Capital Management LLC now owns 174,352 shares of the company’s stock worth $195,000 after purchasing an additional 155,883 shares during the period. Institutional investors own 56.91% of the company’s stock.

About Acutus Medical

Acutus Medical, Inc, an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.